1. Late HCC onset after direct antiviral agents therapy in patients with sustained virological response: do we need to reconsider their efficacy according to long term follow-up?. (3rd August 2018) Authors: Perrella, A.; Izzi, A.; Punzi, R.; Adinolfi, E.; Sbreglia, C.; Bellopede, P.; Galeota Lanza, A.; Martucci, F.; Rinaldi, L. Journal: Scandinavian journal of gastroenterology Issue: Volume 53:Number 8(2018) Page Start: 1025 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety of new DAAs for chronic HCV infection in a real life experience: role of a surveillance network based on clinician and hospital pharmacist. Issue 1 (December 2017) Authors: Nappi, A.; Perrella, A.; Bellopede, P.; Lanza, A.; Izzi, A.; Spatarella, M.; Sbreglia, C. Journal: Infectious agents and cancer Issue: Volume 12:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗